SCHEMBL2669622

SCHEMBL2669622

CO[P@@](C)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14930842 1.00
SCHEMBL411587 1.00
Ammonia Solution, Strong SCHEMBL11792641 0.96
Phosphoric Acid SCHEMBL8603696 0.96 CA2 (0.50)
Hydrochloric Acid SCHEMBL11418241 0.96
SCHEMBL9584149 0.96
SCHEMBL827261 0.96
SCHEMBL9583823 0.96
SCHEMBL9639589 0.96
SCHEMBL28959422 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216252-A1 RETINOL FORMULATION (III) DSM IP ASSETS B.V. (NL) 2024-07-04 US disclosed
WO-2024121183-A1 NEW CYANOPYRIDINE KHK INHIBITOR COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-06-13 WO disclosed
US-20240067967-A1 OPTIMIZED ANTI-FLT1 OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS UNIV MASSACHUSETTS (US) 2024-02-29 US disclosed
US-20230399645-A1 OPTIMIZED SIRNA SCAFFOLDS UNIVERSITY OF MASSACHUSETTS 2023-12-14 US disclosed
EP-4276154-A2 COMPOSITION AND LAMINATED BODY Daikin Industries, Ltd. (JP) 2023-11-15 EP disclosed
US-20230348907-A1 OLIGONUCLEOTIDES FOR MECP2 MODULATION UNIVERSITY OF MASSACHUSETTS 2023-11-02 US disclosed
US-20230340475-A1 OLIGONUCLEOTIDES FOR MLH1 MODULATION UNIV MASSACHUSETTS (US) 2023-10-26 US disclosed
EP-3279271-B1 BACK SHEET FOR SOLAR CELL WITH IMPROVED ADHESION TO AN EVA ENCAPSULANT LAYER DAIKIN IND LTD (JP) 2023-10-25 EP disclosed
US-20230313198-A1 OLIGONUCLEOTIDES FOR MLH3 MODULATION UNIV MASSACHUSETTS (US) 2023-10-05 US disclosed
US-11771688-B2 Pyridine derivatives substituted by heterocyclic ring and amino group AMPLYX PHARMACEUTICALS, INC. (US) 2023-10-03 US disclosed
US-20070131906-A1 Rare-earth phosphate colloidal dispersion, method for the production thereof and a transparent luminescent material obtainable from said dispersion RHODIA ELECTRONICS (FR) 2007-06-14 US disclosed
US-20070135383-A1 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors ILYPSA, INC. 2007-06-14 US disclosed
US-7220854-B1 Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) 2007-05-22 US disclosed
US-7214726-B2 Methods of using two-part self-adhering dental compositions KERR CORPORATION (US) 2007-05-08 US disclosed
US-20070088097-A1 TWO-PART SELF-ADHERING DENTAL COMPOSITIONS KERR CORPORATION (US) 2007-04-19 US disclosed
US-20070060536-A1 Novel reagent compounds and methods of making and using the same UNIVERSITY OF HOUSTON (US) 2007-03-15 US disclosed
US-7176269-B2 Curable composition and its use MITSUI CHEMICALS, INC. (JP) 2007-02-13 US disclosed
US-7166651-B2 Two-part self-adhering dental compositions KERR CORPORATION (US) 2007-01-23 US disclosed
US-20070015893-A1 Curable composition and its use MITSUI CHEMICALS, INC. 2007-01-18 US disclosed
US-20070003975-A1 Structured construct and producing method therefor CANON KABUSHIKI KAISHA (JP) 2007-01-04 US disclosed